- ASSISTANT PROFESSOR Medicine, Endocrinology, Diabetes and Bone Disease
Kondegowda N, Mozar A, Chin C, Otero A, Garcia-Ocana A, Vasavada RC. Lactogens protect rodent and human beta cells against glucolipotoxicity-induced cell death through Jak2/Stat5 signaling. Diabetologia 2012; 55: 1721-32.
Kondegowda NG, Joshi-Gokhale S, Harb G, Williams K, Zhang XY, Takane KK, Zhang P, Scott DK, Stewart AF, Garcia-Ocana A, Vasavada RC. Parathyroid hormone-related protein enhances human β-cell proliferation and function with associated induction of cyclin-dependent-kinase 2 and cyclin E expression.. Diabates 2012; 59(12): 3131-3138.
Williams K, Abanquah D, Joshi-Gokhale S, Otero A, Lin H, Kondegowda NG, Zhang XY, Mozar A, Bisello A, Stewart AF, Garcia-Ocana A, Vasavada RC. Systemic administration of parathyroid hormone-related peptide 1-36 stimulates endogenous beta cell growth while preserving function in adult mice. Diabetologia 2011; 54: 2867-77.
Kondegowda NG, Meaney MP, Baker C, Ju YH. Effects of non-digestible carbohydrates on the growth of estrogen-dependent human breast cancer (MCF-7) tumor implanted in ovariectomized athymic mice. Nutrition and Cancer 2011; 63: 55-64.
Guthalu NK, Balaraman M, Kadimi US. Optimization of enzymatic hydrolysis of triglycerides in soy deodorized distillate with supercritical carbon dioxide.. Biochemical Engineering Journal 2006; 29: 220-26.
Kondegowda NG, Manohar B, Sankar KU. Enzymatic esterification of free fatty acids of hydrolysed soy deodorizer distillate in supercritical carbon dioxide. Journal of Supercritical Fluids 2004; 32: 137-145.
Kondegowda NG, Subramanian R, Sankar KU. Processing of tocopherols and fatty acids systems using a nonporous denser polymeric membrane. Journal of American Oil Chemists Society 2003; 80: 397-402.
Kondegowda NG, Manohar B, Sankar KU. Enrichment of tocopherols in modified soy deodorizer distillate using supercritical carbon dioxide extraction. European Journal of Food Research and Technology 2003; 217: 427-433.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Kondegowda did not report having any of the following types of financial relationships with industry during 2014 and/or 2015: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Mount Sinai Health System (MSHS) physicians - including those employed by MSHS - do not always participate in the same health plans in which MSHS hospitals or facilities participate.
Information regarding insurance participation and billing by this physician may be found on this page or obtained by contacting this provider directly.
Insurance plans that the Mount Sinai Health System hospitals or facilities participate in can be found on the Mount Sinai Health System website.
Atran Berg Laboratory Building Floor 5th floor Room Ab5-02
1428 Madison Avenue
New York, NY 10029